Amgen Historical Balance Sheet

AMGN Stock

USD 307.42 1.57 0.51%

Trend analysis of Amgen Inc balance sheet accounts such as Short Long Term Debt Total of 67.8 B, Other Current Liabilities of 16.1 B or Total Current Liabilities of 19.3 B provides information on Amgen's total assets, liabilities, and equity, which is the actual value of Amgen Inc to its prevalent stockholders. By breaking down trends over time using Amgen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Amgen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Amgen Inc is a good buy for the upcoming year.

Amgen Inventory

9.99 Billion

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Amgen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Amgen Inc at a specified time, usually calculated after every quarter, six months, or one year. Amgen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amgen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amgen currently owns. An asset can also be divided into two categories, current and non-current.

Amgen Balance Sheet Chart

At this time, Amgen's Cash is very stable compared to the past year. As of the 4th of June 2024, Non Current Assets Total is likely to grow to about 70.2 B, while Property Plant And Equipment Net is likely to drop about 3.6 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Other Current Assets Long Term Debt

Add Fundamental

Total Assets

Total assets refers to the total amount of Amgen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amgen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Amgen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amgen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Current Assets

Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.

Long Term Debt

Long-term debt is a debt that Amgen Inc has held for over one year. Long-term debt appears on Amgen Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Amgen Inc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most accounts from Amgen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	33.3B	38.9B	64.6B	67.8B
Total Assets	61.2B	65.1B	97.2B	102.0B

Short Long Term Debt Total Total Assets

Amgen balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Inventory	Accounts Payable	Common Stock Total Equity	Short Term Investments	Capital Stock
Total Assets		0.93	0.74	0.81	0.33	0.65	0.94	-0.4	0.67	0.86	0.63	0.35	0.78	-0.49	0.92	-0.19	0.47	0.91	0.63	0.52	0.26	0.76	0.81	0.79	0.37	0.77
Short Long Term Debt Total	0.93		0.89	0.91	-0.01	0.47	0.99	-0.61	0.83	0.95	0.84	0.02	0.94	-0.55	0.99	-0.25	0.72	0.99	0.81	0.21	0.12	0.95	0.82	0.64	0.08	0.6
Other Current Liab	0.74	0.89		0.95	-0.37	0.39	0.85	-0.88	0.93	0.92	0.95	-0.3	0.99	-0.73	0.92	-0.21	0.84	0.94	0.9	-0.07	-0.06	0.93	0.88	0.58	-0.29	0.54
Total Current Liabilities	0.81	0.91	0.95		-0.23	0.47	0.88	-0.81	0.87	0.9	0.83	-0.12	0.94	-0.76	0.92	-0.29	0.73	0.95	0.82	0.1	0.25	0.88	0.89	0.67	-0.12	0.63
Total Stockholder Equity	0.33	-0.01	-0.37	-0.23		0.39	0.07	0.66	-0.35	-0.12	-0.44	0.88	-0.29	0.37	-0.05	0.17	-0.51	-0.09	-0.36	0.79	0.36	-0.27	-0.11	0.31	0.88	0.36
Property Plant And Equipment Net	0.65	0.47	0.39	0.47	0.39		0.46	-0.32	0.42	0.47	0.21	0.4	0.4	-0.53	0.48	0.22	0.1	0.49	0.35	0.63	0.28	0.3	0.59	0.96	0.27	0.95
Net Debt	0.94	0.99	0.85	0.88	0.07	0.46		-0.53	0.76	0.93	0.79	0.09	0.89	-0.51	0.98	-0.32	0.68	0.97	0.76	0.27	0.17	0.92	0.8	0.63	0.16	0.59
Retained Earnings	-0.4	-0.61	-0.88	-0.81	0.66	-0.32	-0.53		-0.85	-0.71	-0.81	0.56	-0.82	0.79	-0.66	0.13	-0.74	-0.7	-0.79	0.33	0.11	-0.72	-0.76	-0.46	0.62	-0.43
Cash	0.67	0.83	0.93	0.87	-0.35	0.42	0.76	-0.85		0.85	0.88	-0.31	0.94	-0.58	0.85	0.08	0.79	0.87	0.87	-0.1	-0.1	0.89	0.77	0.56	-0.32	0.51
Non Current Assets Total	0.86	0.95	0.92	0.9	-0.12	0.47	0.93	-0.71	0.85		0.88	-0.18	0.95	-0.65	0.96	-0.26	0.74	0.96	0.83	0.04	0.01	0.94	0.85	0.65	-0.14	0.61
Non Currrent Assets Other	0.63	0.84	0.95	0.83	-0.44	0.21	0.79	-0.81	0.88	0.88		-0.44	0.95	-0.61	0.86	-0.22	0.9	0.86	0.91	-0.24	-0.28	0.93	0.74	0.39	-0.39	0.34
Cash And Short Term Investments	0.35	0.02	-0.3	-0.12	0.88	0.4	0.09	0.56	-0.31	-0.18	-0.44		-0.26	0.21	0.0	0.09	-0.48	-0.03	-0.34	0.94	0.49	-0.28	-0.01	0.35	0.97	0.39
Net Receivables	0.78	0.94	0.99	0.94	-0.29	0.4	0.89	-0.82	0.94	0.95	0.95	-0.26		-0.65	0.95	-0.17	0.84	0.96	0.91	-0.04	-0.04	0.97	0.84	0.58	-0.23	0.53
Common Stock Shares Outstanding	-0.49	-0.55	-0.73	-0.76	0.37	-0.53	-0.51	0.79	-0.58	-0.65	-0.61	0.21	-0.65		-0.61	0.39	-0.5	-0.65	-0.6	-0.07	-0.14	-0.51	-0.81	-0.68	0.31	-0.65
Non Current Liabilities Total	0.92	0.99	0.92	0.92	-0.05	0.48	0.98	-0.66	0.85	0.96	0.86	0.0	0.95	-0.61		-0.26	0.72	1.0	0.81	0.2	0.07	0.93	0.88	0.67	0.04	0.62
Other Current Assets	-0.19	-0.25	-0.21	-0.29	0.17	0.22	-0.32	0.13	0.08	-0.26	-0.22	0.09	-0.17	0.39	-0.26		-0.2	-0.27	-0.13	0.06	-0.26	-0.2	-0.28	0.03	-0.01	0.05
Other Stockholder Equity	0.47	0.72	0.84	0.73	-0.51	0.1	0.68	-0.74	0.79	0.74	0.9	-0.48	0.84	-0.5	0.72	-0.2		0.73	0.96	-0.31	-0.25	0.84	0.59	0.24	-0.42	0.18
Total Liab	0.91	0.99	0.94	0.95	-0.09	0.49	0.97	-0.7	0.87	0.96	0.86	-0.03	0.96	-0.65	1.0	-0.27	0.73		0.83	0.18	0.11	0.93	0.89	0.68	0.01	0.63
Property Plant And Equipment Gross	0.63	0.81	0.9	0.82	-0.36	0.35	0.76	-0.79	0.87	0.83	0.91	-0.34	0.91	-0.6	0.81	-0.13	0.96	0.83		-0.13	-0.16	0.87	0.73	0.47	-0.32	0.43
Total Current Assets	0.52	0.21	-0.07	0.1	0.79	0.63	0.27	0.33	-0.1	0.04	-0.24	0.94	-0.04	-0.07	0.2	0.06	-0.31	0.18	-0.13		0.5	-0.09	0.22	0.6	0.89	0.61
Short Term Debt	0.26	0.12	-0.06	0.25	0.36	0.28	0.17	0.11	-0.1	0.01	-0.28	0.49	-0.04	-0.14	0.07	-0.26	-0.25	0.11	-0.16	0.5		-0.07	0.05	0.31	0.47	0.32
Inventory	0.76	0.95	0.93	0.88	-0.27	0.3	0.92	-0.72	0.89	0.94	0.93	-0.28	0.97	-0.51	0.93	-0.2	0.84	0.93	0.87	-0.09	-0.07		0.74	0.47	-0.19	0.4
Accounts Payable	0.81	0.82	0.88	0.89	-0.11	0.59	0.8	-0.76	0.77	0.85	0.74	-0.01	0.84	-0.81	0.88	-0.28	0.59	0.89	0.73	0.22	0.05	0.74		0.77	-0.05	0.76
Common Stock Total Equity	0.79	0.64	0.58	0.67	0.31	0.96	0.63	-0.46	0.56	0.65	0.39	0.35	0.58	-0.68	0.67	0.03	0.24	0.68	0.47	0.6	0.31	0.47	0.77		0.24	0.99
Short Term Investments	0.37	0.08	-0.29	-0.12	0.88	0.27	0.16	0.62	-0.32	-0.14	-0.39	0.97	-0.23	0.31	0.04	-0.01	-0.42	0.01	-0.32	0.89	0.47	-0.19	-0.05	0.24		0.26
Capital Stock	0.77	0.6	0.54	0.63	0.36	0.95	0.59	-0.43	0.51	0.61	0.34	0.39	0.53	-0.65	0.62	0.05	0.18	0.63	0.43	0.61	0.32	0.4	0.76	0.99	0.26

Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	59.7B	62.9B	61.2B	65.1B	97.2B	102.0B
Short Long Term Debt Total	29.9B	33.0B	33.3B	38.9B	64.6B	67.8B
Other Current Liab	8.5B	10.1B	10.7B	12.5B	15.4B	16.1B
Total Current Liabilities	12.8B	11.7B	12.2B	15.7B	18.4B	19.3B
Total Stockholder Equity	9.7B	9.4B	6.7B	3.7B	6.2B	12.3B
Property Plant And Equipment Net	4.9B	4.9B	5.2B	5.4B	5.9B	3.6B
Net Debt	23.9B	26.7B	25.3B	31.3B	53.7B	56.4B
Retained Earnings	(21.3B)	(21.4B)	(24.6B)	(28.6B)	(26.5B)	(25.2B)
Cash	6.0B	6.3B	8.0B	7.6B	10.9B	11.5B
Non Current Assets Total	41.3B	41.8B	41.8B	42.9B	66.8B	70.2B
Non Currrent Assets Other	2.2B	5.6B	6.5B	5.9B	9.6B	10.1B
Cash And Short Term Investments	8.9B	10.6B	8.0B	9.3B	10.9B	10.5B
Net Receivables	4.1B	4.5B	4.9B	5.6B	7.9B	8.3B
Common Stock Shares Outstanding	609M	590M	573M	541M	538M	759.2M
Liabilities And Stockholders Equity	59.7B	62.9B	61.2B	65.1B	97.2B	102.0B
Non Current Liabilities Total	37.2B	41.9B	42.3B	45.8B	72.5B	76.2B
Other Current Assets	1.9B	2.1B	2.4B	2.4B	281M	267.0M
Other Stockholder Equity	(528M)	(985M)	18.2B	21.7B	25.0B	26.2B
Total Liab	50.0B	53.5B	54.5B	61.5B	90.9B	95.5B
Property Plant And Equipment Gross	4.9B	4.9B	14.0B	14.7B	15.7B	16.5B
Total Current Assets	18.4B	21.1B	19.4B	22.2B	30.3B	15.2B
Accumulated Other Comprehensive Income	(528M)	(985M)	(796M)	(231M)	(289M)	(274.6M)
Short Term Debt	3.0B	91M	87M	1.6B	1.4B	1.0B
Inventory	3.6B	3.9B	4.1B	4.9B	9.5B	10.0B
Accounts Payable	1.4B	1.4B	1.4B	1.6B	1.6B	1.7B
Common Stock Total Equity	31.5B	31.8B	32.1B	32.5B	37.4B	27.1B
Short Term Investments	2.9B	4.4B	48M	1.7B	10.9B	12.2B
Capital Stock	31.5B	31.8B	32.1B	32.5B	33.1B	27.5B
Common Stock	31.5B	31.8B	32.1B	32.5B	33.1B	27.5B
Other Assets	955M	1.3B	6.5B	2.2B	2.5B	1.4B
Long Term Debt	27.0B	32.9B	33.2B	37.4B	63.2B	66.3B
Property Plant Equipment	4.9B	4.9B	5.2B	5.4B	6.2B	5.3B
Good Will	14.7B	14.7B	14.9B	15.5B	18.6B	14.4B
Intangible Assets	19.4B	16.6B	15.2B	16.1B	32.6B	34.3B
Other Liab	9.9B	9.0B	9.1B	7.9B	9.1B	5.1B
Net Tangible Assets	(24.4B)	(21.9B)	(23.4B)	(27.9B)	(25.2B)	(23.9B)
Retained Earnings Total Equity	(21.3B)	(21.4B)	(24.6B)	(28.6B)	(25.8B)	(24.5B)
Long Term Debt Total	27.0B	32.9B	33.2B	37.4B	43.0B	29.9B
Non Current Liabilities Other	9.6B	9.0B	2.5B	2.7B	2.3B	2.2B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Amgen Stock

When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:

How To Invest In Amgen

Details

Is Amgen Stock a good investment?

Details

What is Amgen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.52)

Dividend Share

8.64

Earnings Share

Revenue Per Share

55.148

Quarterly Revenue Growth

0.22

The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Amgen Historical Balance Sheet

Amgen Inventory

9.99 Billion

About Amgen Balance Sheet Analysis

Amgen Balance Sheet Chart

Total Assets

Total Current Liabilities

Other Current Assets

Long Term Debt

Amgen balance sheet Correlations

Amgen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Amgen balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Additional Information and Resources on Investing in Amgen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Non Current Liabilities Total
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Net Receivables	+ 0.99	Other Current Liab
Capital Stock	+ 0.99	Common Stock Total Equity

Retained Earnings	- 0.88	Other Current Liab
Cash	- 0.85	Retained Earnings
Net Receivables	- 0.82	Retained Earnings
Accounts Payable	- 0.81	Common Stock Shares Outstanding
Non Currrent Assets Other	- 0.81	Retained Earnings
Retained Earnings	- 0.81	Total Current Liabilities